NCT01840241

Brief Summary

In this single-site, randomized, controlled and double-blind clinical trial, the investigators evaluate the effect of sodium bicarbonate on prevention of acute kidney injury in high risk patients undergoing off pump coronary bypass surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
162

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

April 17, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 25, 2013

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2015

Completed
Last Updated

October 27, 2017

Status Verified

October 1, 2017

Enrollment Period

2.6 years

First QC Date

April 17, 2013

Last Update Submit

October 25, 2017

Conditions

Keywords

sodium bicarbonateacute kidney injuryOPCAB

Outcome Measures

Primary Outcomes (1)

  • compare the incidence of acute kidney injury

    The diagnostic criteria for AKI is followed by AKIN criteria (absolutely increase in the SCr concentration ≥ 0.3 mg/dL from baseline, ≥ 50% increase in the SCr concentration within 48 hours after operation).

    Change of Indexes of renal function including SCr, cystatin C, creatinine clearance from 24 hrs before operation to postoperative day (POD) 5.

Study Arms (2)

BIVON group

EXPERIMENTAL
Drug: sodium bicarbonate

Placebo group

PLACEBO COMPARATOR

normal saline infusion

Drug: normal saline

Interventions

BIVON group were received 0.5 mmol/kg of sodium bicarbonate for 1hours after induction of anesthesia and following 0.15 mmol/kg of sodium bicarbonate during the operation.

BIVON group
Placebo group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients older than 20 years
  • scheduled for elective coronary artery bypass grafting.
  • preoperative estimated glomerular filtration rate (eGFR) : 30 \~ 89 %
  • LVEF \< 35%
  • NYHA class III or IV
  • age \> 70
  • reoperation

You may not qualify if:

  • acute renal impairment
  • patients who receive dialysis
  • patients who receive steroid ( \> 10mg/day prednisolon or equivalent)
  • hemo-alkalosis
  • hypernatremia
  • pulmonary edema
  • Hemoglobin \< 10 mg/dL

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of anesthesiology and pain medicine

Seoul, 120-752, South Korea

Location

Related Publications (1)

  • Soh S, Song JW, Shim JK, Kim JH, Kwak YL. Sodium bicarbonate does not prevent postoperative acute kidney injury after off-pump coronary revascularization: a double-blinded randomized controlled trial. Br J Anaesth. 2016 Oct;117(4):450-457. doi: 10.1093/bja/aew256. Epub 2016 Oct 17.

MeSH Terms

Conditions

Acute Kidney Injury

Interventions

Sodium BicarbonateSaline Solution

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

BicarbonatesCarbonatesCarbonic AcidCarbon Compounds, InorganicInorganic ChemicalsSodium CompoundsCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2013

First Posted

April 25, 2013

Study Start

April 1, 2013

Primary Completion

October 20, 2015

Study Completion

October 20, 2015

Last Updated

October 27, 2017

Record last verified: 2017-10

Locations